Learning Objectives:
- Quantify the combined effects of SGLT2i, ns-MRA, and GLP-1RA on kidney disease
- Explore the physiology of these medications further
- Identify points of our current practice that we can change to improve the outcomes for our patients
Session date:
12/22/2023 - 12:00pm to 1:00pm CST
Location:
Via Zoom
5841 S. Maryland Ave
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Gilad Guez, MD